0001213900-21-037558.txt : 20210819 0001213900-21-037558.hdr.sgml : 20210819 20210719191146 ACCESSION NUMBER: 0001213900-21-037558 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20210719 FILER: COMPANY DATA: COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001728328 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 BUSINESS PHONE: (604) 669-7207 MAIL ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 CORRESP 1 filename1.htm

July 19, 2021

VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance

Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549

Re:

InMed Pharmaceuticals Inc.

Registration Statement on Form S-1

Filed July 13, 2021

File No. 333-257858

Ladies and Gentlemen:

On behalf of InMed Pharmaceuticals Inc., a British Columbia corporation (the “Company”), the undersigned hereby respectfully requests the withdrawal of a previously filed letter to the SEC (Accession Number: 0001213900-21-037519) and hereby resubmits its request for acceleration of effectiveness. Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, the undersigned hereby requests that the effective date of the above referenced Registration Statement on Form S-1 (the “Registration Statement”), be accelerated so that the same will become effective at 9:00 a.m., Washington, D.C. time, on Thursday, July 22, 2021, or as soon as practicable thereafter.

Please notify Brian P. Fenske of Norton Rose Fulbright US LLP, counsel to the Company, at (713) 651-5557, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter.

	Very truly yours,

	InMed Pharmaceuticals Inc.
	By:	/s/ Eric A. Adams
	Name:	Eric A. Adams
	Title:	President and Chief Executive Officer

GRAPHIC 2 image_003.jpg GRAPHIC begin 644 image_003.jpg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end